# Phase <scp>II</scp> study of dual phosphoinositol‐3‐kinase ( <scp>PI</scp> 3K) and mammalian target of rapamycin ( <scp>mTOR</scp> ) inhibitor <scp>BEZ</scp> 235 in patients with locally advanced or metastatic transitional cell carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-scp-ii-scp-study-of-dual-phosphoinositol-3-kinase-scp-pi-scp-3k-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Emmanuel Seront,Sylvie Rottey,Bertrand Filleul,Philippe Glorieux,Jean‐Charles Goeminne,Vincent Verschaeve,Jean‐Marie Vandenbulcke,Brieuc Sautois,Petra Boegner,Aline Gillain,Aline van Maanen,Jean‐Pascal Machiels |
| Citations | 60 |
| DOI | 10.1111/bju.13415 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://orbi.uliege.be/handle/2268/209343 |
| OpenAlex ID | https://openalex.org/W2299607852 |
| PMID | 26779597 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Vincent Verschaeve](https://scholariq.org/researchers/vincent-verschaeve/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.